South Africa /
The vaccine Johnson & Johnson against COVID-19 has a 66% overall efficiency, although less so in South Africa, where a variant of the most contagious coronavirusthe US pharmaceutical company announced in a statement on Friday.
The vaccine, which requires only one injection, is effective in a 85% to prevent serious forms of the disease, according to an extensive clinical trial.
It is expected Johnson & Johnson Apply for an emergency distribution permit in the United States starting next week.
Two vaccines against COVID-19 are currently circulating in the country adding the most deaths from the pandemic: that of Moderna and Pfizer-BioNTech.
The potential sum of one-third comes at a time when the United States is trying to speed up its immunization rate to achieve the new president’s goal, Joe Biden, 1.5 million doses injected per day.
The group promised to send 100 million doses to the United States a few before the end of June 200 million doses to the European Union before the end of the year, with the first shipments in April, and an additional 200 million to developing countries starting in June.
Just like vaccines Pfizer and Moderna, The “J&J” immunizer sends genetic instructions to the cells of the human body to produce a specific protein coronavirus, which can train the immune system to respond appropriately to the real virus.
Easy distribution
The vaccine Johnson & Johnson however, can be stored at normal refrigerator temperatures, and not in freezers, which facilitates its distribution.
The fact is, you don’t have to worry.